Cardinal Health: Can Its Strategic Acquisitions & Improving Market Position Be A Sustainable Growth Accelerator? 

Cardinal Health, Inc. reported strong financial and operational results for the first quarter of fiscal year 2025, primarily driven by its Pharmaceutical and Specialty Solutions segment. CEO Jason Hollar highlighted the company’s effective management amidst a customer transition in its largest business segment, which still achieved a 16% growth in segment profit. The demand across various pharmaceutical categories, notably specialty and consumer health, played a significant role in this growth. The team’s efficient execution during a customer transition and support during the COVID-19 vaccine distribution were also pivotal components of their success.